Skip to main content

Birchview Capital, LP

13F filer · CIK 0001618205
Reported Aug 14, 2026
Net seller this quarter
13F portfolio value$214MU.S. long equity reported on 13F
Positions7214 new · 15 closed
Net flow last quarter-$16.8MBuys minus sells
Top 10 positions weight59.9%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Aug 14, 202672 positions
KLACKla Corp$53.8M25.18%0.01%-10.2%Q2 2025
BMYBristol Myers Squibb Co$17.1M8.01%0.01%-3.0%Q3 2020
LRCXLam Research Corp$15.2M7.09%0.00%-2.8%Q4 2025
NTLAIntellia Therapeutics, Inc.$6.78M3.17%0.28%-13.4%Q2 2025
SLDBSolid Biosciences Inc.$6.66M3.11%0.63%+6.4%Q1 2025
BDSXBiodesix Inc$6.47M3.02%2.72%Not reportedQ4 2020
STOKStoke Therapeutics, Inc.$5.83M2.73%0.29%-15.2%Q3 2020
OVVOvintiv Inc.$5.66M2.65%0.04%Not reportedQ3 2020
NKTRNektar Therapeutics$5.65M2.64%0.40%+161.3%Q1 2021
CORTCorcept Therapeutics Inc$4.97M2.33%0.05%+21.2%Q4 2015
NBIXNeurocrine Biosciences Inc$4.58M2.14%0.03%Not reportedQ3 2015
PRTAProthena Corp Public Ltd Co$4.4M2.06%0.87%Not reportedQ2 2021
ACADAcadia Pharmaceuticals Inc$4.33M2.02%0.10%Not reportedQ3 2020
PTGXProtagonist Therapeutics, Inc$4.29M2.01%0.05%+0.1%Q1 2021
CMPXCompass Therapeutics, Inc.$3.67M1.72%0.93%+14.3%Q1 2025
RLMDRelmada Therapeutics, Inc.$2.82M1.32%0.38%-0.3%Q1 2026
ALKSAlkermes plc.$2.62M1.23%0.03%Not reportedQ1 2021
HALOHalozyme Therapeutics, Inc.$2.6M1.22%0.03%+229.2%Q4 2022
CLDXCelldex Therapeutics, Inc.$2.6M1.22%0.09%-0.3%Q1 2026
CYTKCytokinetics Inc$2.56M1.20%0.02%Not reportedQ2 2021
OLMAOlema Pharmaceuticals, Inc.$2.49M1.16%0.23%-9.1%Q2 2025
VERAVera Therapeutics, Inc.$2.48M1.16%0.08%+31.3%Q4 2025
UTHRUNITED THERAPEUTICS Corp$2.44M1.14%0.01%+0.1%Q3 2020
ZBIOZenas BioPharma, Inc.$2.38M1.11%0.15%+33.7%Q4 2024
QUREuniQure N.V.$2.34M1.09%0.07%-49.7%Q3 2024
PACBPacific Biosciences of California, Inc.$2.27M1.06%0.43%-10.0%Q2 2025
ABVXAbivax S.A.$2.27M1.06%0.02%NewQ2 2026
VIRVir Biotechnology, Inc.$2.24M1.05%0.13%NewQ2 2026
BIIBBiogen Inc.$1.94M0.91%0.01%+80.0%Q4 2014
EQTEQT Corp$1.84M0.86%0.01%Not reportedQ4 2014
BIOABioAge Labs, Inc.$1.69M0.79%0.15%NewQ2 2026
TVTXTravere Therapeutics, Inc.$1.65M0.77%0.03%-0.7%Q2 2023
QDELQuidelOrtho Corp$1.57M0.73%0.13%+8.3%Q4 2014
AXSMAxsome Therapeutics, Inc.$1.47M0.69%0.01%Not reportedQ1 2024
FHTXFoghorn Therapeutics Inc.$1.38M0.64%0.48%+0.1%Q4 2020
BCYCBicycle Therapeutics PLC$1.33M0.62%0.45%-32.4%Q3 2025
GPCRStructure Therapeutics Inc.$1.29M0.60%0.01%-76.0%Q2 2025
XENEXenon Pharmaceuticals Inc.$1.27M0.59%0.02%+0.2%Q2 2022
NVONovo Nordisk A S$1.15M0.54%Not reportedNewQ2 2026
FCXFreeport-Mcmoran Inc$1.13M0.53%0.00%0.0%Q2 2025
IMNMImmunome Inc.$1.06M0.50%0.04%Not reportedQ2 2025
PHVSPharvaris N.V.$1.03M0.48%0.05%Not reportedQ3 2025
HROWHarrow, Inc.$1.02M0.48%0.06%Not reportedQ3 2020
ADAGAdagene Inc.$1.01M0.47%0.41%NewQ2 2026
DFTXDefinium Therapeutics, Inc.$941K0.44%0.01%NewQ2 2026
SLNSilence Therapeutics plc$782K0.37%0.05%NewQ2 2026
BBIOBridgeBio Pharma, Inc.$651K0.30%0.00%+0.6%Q2 2025
FDMT4D Molecular Therapeutics, Inc.$645K0.30%0.09%NewQ2 2026
URGNUroGen Pharma Ltd.$607K0.28%0.03%NewQ2 2026
PHATPhathom Pharmaceuticals, Inc.$597K0.28%0.07%-71.8%Q2 2025
Q1 2026Reported May 15, 202673 positions
KLACKla Corp$29.3M16.67%0.02%-9.1%Q2 2025
BMYBristol Myers Squibb Co$18.6M10.57%0.02%+1.1%Q3 2020
CMPXCompass Therapeutics, Inc.$7.75M4.41%0.81%-8.0%Q1 2025
LRCXLam Research Corp$7.69M4.38%0.00%-10.7%Q4 2025
STOKStoke Therapeutics, Inc.$6.84M3.89%0.34%-19.2%Q3 2020
OVVOvintiv Inc.$6.38M3.63%0.04%Not reportedQ3 2020
NTLAIntellia Therapeutics, Inc.$5.71M3.25%0.37%+41.2%Q2 2025
GPCRStructure Therapeutics Inc.$4.82M2.74%0.05%+11.1%Q2 2025
SLDBSolid Biosciences Inc.$4.51M2.57%0.64%-11.3%Q1 2025
PRTAProthena Corp Public Ltd Co$4.36M2.48%0.85%+1.8%Q2 2021
BDSXBiodesix Inc$4.16M2.37%2.84%Not reportedQ4 2020
ACADAcadia Pharmaceuticals Inc$3.81M2.17%0.10%Not reportedQ3 2020
PTGXProtagonist Therapeutics, Inc$3.69M2.10%0.05%-36.4%Q1 2021
NBIXNeurocrine Biosciences Inc$3.58M2.04%0.03%Not reportedQ3 2015
OLMAOlema Pharmaceuticals, Inc.$3.27M1.86%0.25%-18.6%Q2 2025
RLMDRelmada Therapeutics, Inc.$2.85M1.62%0.39%NewQ1 2026
OCULOcular Therapeutix, Inc$2.71M1.54%0.15%NewQ1 2026
UTHRUNITED THERAPEUTICS Corp$2.67M1.52%0.01%+50.0%Q3 2020
NKTRNektar Therapeutics$2.23M1.27%0.15%Not reportedQ1 2021
CLDXCelldex Therapeutics, Inc.$2.22M1.27%0.11%NewQ1 2026
NVCRNovoCure Ltd$2.21M1.26%0.17%+33.0%Q2 2024
EQTEQT Corp$2.2M1.25%0.01%Not reportedQ4 2014
PHATPhathom Pharmaceuticals, Inc.$2.17M1.23%0.25%Not reportedQ2 2025
BCYCBicycle Therapeutics PLC$2.15M1.22%0.67%+0.2%Q3 2025
CMPSCOMPASS Pathways plc$2.07M1.18%0.28%NewQ1 2026
PACBPacific Biosciences of California, Inc.$1.98M1.13%0.48%+200.0%Q2 2025
CYTKCytokinetics Inc$1.98M1.13%0.02%Not reportedQ2 2021
CORTCorcept Therapeutics Inc$1.9M1.08%0.04%-29.8%Q4 2015
VERAVera Therapeutics, Inc.$1.77M1.01%0.07%Not reportedQ4 2025
ALKSAlkermes plc.$1.77M1.01%0.03%Not reportedQ1 2021
ENGNenGene Therapeutics Inc.$1.7M0.97%0.37%NewQ1 2026
QUREuniQure N.V.$1.65M0.94%0.16%+227.1%Q3 2024
ZBIOZenas BioPharma, Inc.$1.37M0.78%0.11%Not reportedQ4 2024
QDELQuidelOrtho Corp$1.36M0.77%0.12%+13.8%Q4 2014
FHTXFoghorn Therapeutics Inc.$1.35M0.77%0.48%Not reportedQ4 2020
RAREUltragenyx Pharmaceutical Inc.$1.3M0.74%0.06%Not reportedQ4 2024
XENEXenon Pharmaceuticals Inc.$1.22M0.70%0.02%Not reportedQ2 2022
KALVKalVista Pharmaceuticals, Inc.$1.15M0.65%0.11%Not reportedQ3 2020
IMNMImmunome Inc.$1.09M0.62%0.04%-61.5%Q2 2025
FCXFreeport-Mcmoran Inc$1.06M0.60%0.00%0.0%Q2 2025
AXSMAxsome Therapeutics, Inc.$1.01M0.58%0.01%-1.0%Q1 2024
BIIBBiogen Inc.$917K0.52%0.00%Not reportedQ4 2014
LPCNLipocine Inc.$893K0.51%1.50%NewQ1 2026
TVTXTravere Therapeutics, Inc.$868K0.49%0.03%-32.1%Q2 2023
HROWHarrow, Inc.$846K0.48%0.06%-29.4%Q3 2020
PHVSPharvaris N.V.$843K0.48%0.05%Not reportedQ3 2025
VSTMVerastem, Inc.$795K0.45%0.17%Not reportedQ4 2025
APGEApogee Therapeutics, Inc.$758K0.43%0.01%-43.8%Q1 2025
HALOHalozyme Therapeutics, Inc.$653K0.37%0.01%Not reportedQ4 2022
BBIOBridgeBio Pharma, Inc.$645K0.37%0.00%Not reportedQ2 2025
Q4 2025Reported Feb 13, 202668 positions
KLACKla Corp$26.6M15.57%0.02%Not reportedQ2 2025
BMYBristol Myers Squibb Co$16.3M9.56%0.01%-4.4%Q3 2020
CMPXCompass Therapeutics, Inc.$8.55M5.01%0.89%+82.5%Q1 2025
STOKStoke Therapeutics, Inc.$8.25M4.83%0.44%+23.8%Q3 2020
LRCXLam Research Corp$6.9M4.04%0.00%NewQ4 2025
OLMAOlema Pharmaceuticals, Inc.$6.73M3.94%0.33%+54.6%Q2 2025
GPCRStructure Therapeutics Inc.$6.26M3.66%0.04%+15.4%Q2 2025
PTGXProtagonist Therapeutics, Inc$4.8M2.81%0.09%+14.6%Q1 2021
ACADAcadia Pharmaceuticals Inc$4.57M2.67%0.10%Not reportedQ3 2020
OVVOvintiv Inc.$4.21M2.47%0.04%Not reportedQ3 2020
PRTAProthena Corp Public Ltd Co$4.21M2.47%0.82%-19.7%Q2 2021
SLDBSolid Biosciences Inc.$3.98M2.33%0.89%+137.7%Q1 2025
NBIXNeurocrine Biosciences Inc$3.86M2.26%0.03%-5.2%Q3 2015
FOLDAmicus Therapeutics, Inc.$3.6M2.11%0.08%Not reportedQ3 2020
BCYCBicycle Therapeutics PLC$3.28M1.92%0.67%+200.5%Q3 2025
PHATPhathom Pharmaceuticals, Inc.$3.24M1.89%0.27%+129.4%Q2 2025
CSTLCastle Biosciences Inc$3.14M1.84%0.27%-27.1%Q4 2023
NTLAIntellia Therapeutics, Inc.$2.84M1.66%0.27%+425.7%Q2 2025
IMNMImmunome Inc.$2.79M1.63%0.11%+23.8%Q2 2025
CORTCorcept Therapeutics Inc$2.34M1.37%0.06%Not reportedQ4 2015
VERAVera Therapeutics, Inc.$2.23M1.30%0.07%NewQ4 2025
QDELQuidelOrtho Corp$2.07M1.21%0.11%Not reportedQ4 2014
NVCRNovoCure Ltd$1.97M1.15%0.14%+49.0%Q2 2024
BDSXBiodesix Inc$1.95M1.14%3.48%Not reportedQ4 2020
CYTKCytokinetics Inc$1.91M1.12%0.02%Not reportedQ2 2021
PHRPhreesia, Inc.$1.87M1.10%0.18%-3.5%Q1 2022
EQTEQT Corp$1.86M1.09%0.01%Not reportedQ4 2014
HROWHarrow, Inc.$1.67M0.98%0.09%-15.0%Q3 2020
TVTXTravere Therapeutics, Inc.$1.64M0.96%0.05%-0.1%Q2 2023
FHTXFoghorn Therapeutics Inc.$1.52M0.89%0.50%Not reportedQ4 2020
UTHRUNITED THERAPEUTICS Corp$1.46M0.86%0.01%Not reportedQ3 2020
RAREUltragenyx Pharmaceutical Inc.$1.43M0.83%0.06%+181.8%Q4 2024
ALKSAlkermes plc.$1.4M0.82%0.03%Not reportedQ1 2021
NKTRNektar Therapeutics$1.31M0.77%0.15%+671.0%Q1 2021
APGEApogee Therapeutics, Inc.$1.21M0.71%0.02%Not reportedQ1 2025
VSTMVerastem, Inc.$1.16M0.68%0.19%NewQ4 2025
AXSMAxsome Therapeutics, Inc.$1.11M0.65%0.01%+1.0%Q1 2024
MASIMasimo Corp$1.08M0.63%0.02%Not reportedQ4 2014
TXG10x Genomics, Inc.$962K0.56%0.05%Not reportedQ4 2022
XENEXenon Pharmaceuticals Inc.$941K0.55%0.03%Not reportedQ2 2022
PACBPacific Biosciences of California, Inc.$935K0.55%0.17%Not reportedQ2 2025
KALVKalVista Pharmaceuticals, Inc.$921K0.54%0.11%-14.9%Q3 2020
FCXFreeport-Mcmoran Inc$917K0.54%0.00%0.0%Q2 2025
VTYXVentyx Biosciences, Inc.$910K0.53%0.14%+2.0%Q4 2021
PHVSPharvaris N.V.$828K0.48%0.05%+101.0%Q3 2025
ILMNIllumina, Inc.$787K0.46%0.00%NewQ4 2025
QUREuniQure N.V.$737K0.43%0.05%-60.9%Q3 2024
HALOHalozyme Therapeutics, Inc.$680K0.40%0.01%Not reportedQ4 2022
BHVNBiohaven Ltd.$670K0.39%0.04%Not reportedQ3 2020
BBIOBridgeBio Pharma, Inc.$665K0.39%0.00%Not reportedQ2 2025
Q3 2025Reported Nov 13, 202568 positions
KLACKla Corp$23.6M17.82%0.02%+38.1%Q2 2025
BMYBristol Myers Squibb Co$14.3M10.79%0.02%-2.0%Q3 2020
CORTCorcept Therapeutics Inc$5.58M4.22%0.06%Not reportedQ4 2015
PRTAProthena Corp Public Ltd Co$5.36M4.05%1.02%+21.7%Q2 2021
STOKStoke Therapeutics, Inc.$4.94M3.73%0.38%Not reportedQ3 2020
QUREuniQure N.V.$4.6M3.47%0.13%-20.2%Q3 2024
OVVOvintiv Inc.$4.34M3.28%0.04%Not reportedQ3 2020
NBIXNeurocrine Biosciences Inc$4.03M3.04%0.03%-7.3%Q3 2015
ACADAcadia Pharmaceuticals Inc$3.65M2.76%0.10%-9.0%Q3 2020
PTGXProtagonist Therapeutics, Inc$3.19M2.41%0.08%Not reportedQ1 2021
CMPXCompass Therapeutics, Inc.$3.06M2.31%0.49%Not reportedQ1 2025
PHRPhreesia, Inc.$2.7M2.04%0.19%Not reportedQ1 2022
CSTLCastle Biosciences Inc$2.52M1.90%0.38%Not reportedQ4 2023
GPCRStructure Therapeutics Inc.$2.18M1.65%0.04%+116.7%Q2 2025
BDSXBiodesix Inc$2.17M1.63%3.61%0.0%Q4 2020
QDELQuidelOrtho Corp$2.14M1.61%0.11%Not reportedQ4 2014
AXGNAxogen, Inc.$2.12M1.60%0.26%-26.0%Q2 2023
FOLDAmicus Therapeutics, Inc.$1.99M1.51%0.08%+803.6%Q3 2020
HROWHarrow, Inc.$1.93M1.46%0.11%-33.3%Q3 2020
EQTEQT Corp$1.88M1.42%0.01%Not reportedQ4 2014
SLDBSolid Biosciences Inc.$1.83M1.38%0.38%+66.1%Q1 2025
OLMAOlema Pharmaceuticals, Inc.$1.7M1.29%0.25%+29.9%Q2 2025
CYTKCytokinetics Inc$1.65M1.24%0.03%+200.0%Q2 2021
ALKSAlkermes plc.$1.5M1.13%0.03%Not reportedQ1 2021
FHTXFoghorn Therapeutics Inc.$1.38M1.04%0.50%-9.4%Q4 2020
NVCRNovoCure Ltd$1.32M1.00%0.09%+1.1%Q2 2024
UTHRUNITED THERAPEUTICS Corp$1.26M0.95%0.01%-29.4%Q3 2020
IMNMImmunome Inc.$1.23M0.93%0.11%+75.0%Q2 2025
MASIMasimo Corp$1.22M0.92%0.02%Not reportedQ4 2014
BCYCBicycle Therapeutics PLC$1.19M0.90%0.22%NewQ3 2025
TMCITreace Medical Concepts, Inc.$1.19M0.90%0.28%Not reportedQ3 2024
KNSAKiniksa Pharmaceuticals International, plc$1.16M0.88%Not reportedNot reportedQ2 2021
OMOutset Medical, Inc.$1.11M0.84%0.44%+127.2%Q2 2024
INBXInhibrx Biosciences, Inc.$1.07M0.81%0.22%-1.3%Q4 2021
DCGODocGo Inc.$1.04M0.78%0.78%Not reportedQ4 2021
NTLAIntellia Therapeutics, Inc.$1.04M0.78%0.05%Not reportedQ2 2025
TVTXTravere Therapeutics, Inc.$1.03M0.78%0.05%-58.2%Q2 2023
PHATPhathom Pharmaceuticals, Inc.$1M0.76%0.12%+240.0%Q2 2025
SRRKScholar Rock Holding Corp$968K0.73%0.03%+62.5%Q4 2024
XENEXenon Pharmaceuticals Inc.$843K0.64%0.03%Not reportedQ2 2022
KALVKalVista Pharmaceuticals, Inc.$816K0.62%0.13%Not reportedQ3 2020
HALOHalozyme Therapeutics, Inc.$741K0.56%0.01%+1.0%Q4 2022
AXSMAxsome Therapeutics, Inc.$729K0.55%0.01%Not reportedQ1 2024
FCXFreeport-Mcmoran Inc$708K0.53%0.00%+0.1%Q2 2025
RAREUltragenyx Pharmaceutical Inc.$662K0.50%0.02%+22.2%Q4 2024
PACBPacific Biosciences of California, Inc.$640K0.48%0.17%+25.0%Q2 2025
APGEApogee Therapeutics, Inc.$636K0.48%0.03%Not reportedQ1 2025
ELUTElutia Inc.$633K0.48%109.63%-38.6%Q2 2021
VYGRVoyager Therapeutics, Inc.$630K0.48%0.24%Not reportedQ3 2020
ATECAlphatec Holdings, Inc.$480K0.36%0.02%Not reportedQ3 2022
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.